Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.1101/2024.12.12.628248

Modulating Motor Cortex Plasticity via Cortical and Peripheral Somatosensory Stimulation

Bao, S.·Lei, Y.
View original source ↗Export metadata ↓

Abstract

The interaction between the motor and somatosensory systems is essential for effective motor control, with evidence indicating that somatosensory stimulation influences the excitability of the primary motor cortex (M1). However, the mechanisms by which repetitive stimulation of both cortical and peripheral somatosensory systems affects M1 plasticity are not well understood. To investigate this, we examined the effects of continuous theta-burst stimulation (cTBS) applied to the primary somatosensory cortex (S1) and transcutaneous electrical nerve stimulation (TENS) of the median nerve on various measures of corticospinal excitability and M1 intracortical circuits. Specifically, we assessed motor-evoked potentials (MEPs), short-latency intracortical inhibition (SICI), intracortical facilitation (ICF), and short-latency afferent inhibition (SAI) before and after administering cTBS and TENS. Our results demonstrated that cTBS increased MEPs for at least 50 minutes, whereas TENS increased MEPs for 10 minutes. Neither cTBS nor TENS had an impact on SICI and ICF. However, cTBS decreased SAI, while TENS did not affect SAI. The sham procedures for both cTBS and TENS did not produce significant changes in MEPs, SICI, ICF, or SAI. These findings suggest that both cortical and peripheral somatosensory stimulation modulate corticospinal excitability, with the effects of cortical stimulation being more prolonged. Neither type of stimulation influences inhibitory and excitatory intracortical neural circuitry within M1. Notably, cortical somatosensory stimulation modulates the interaction between M1 and S1, whereas peripheral somatosensory stimulation does not. This study elucidates distinct mechanisms through which cortical and peripheral somatosensory stimulation influence M1 plasticity. NEW & NOTEWORTHYThis study identifies distinct mechanisms through which cortical and peripheral somatosensory stimulation influence motor cortex (M1) plasticity. Both continuous theta-burst stimulation (cTBS) of the primary somatosensory cortex (S1) and transcutaneous electrical nerve stimulation (TENS) of the median nerve enhance corticospinal excitability, with cTBS exhibiting longer-lasting effects. Importantly, cTBS, but not TENS, modulates the interaction between M1 and S1. These findings form the basis for developing targeted somatosensory interventions aimed at modulating motor function.

Source connections

Explore related subjects

neurosciencePreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Bao, S., Lei, Y.. 2024-12-17. Modulating Motor Cortex Plasticity via Cortical and Peripheral Somatosensory Stimulation. https://doi.org/10.1101/2024.12.12.628248

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗
bioRxiv2026

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗
bioRxiv2026

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗